TrialAntimicrobial agents and chemotherapy2013

Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.

Luciana Annino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.